Acting Editor-in-Chief
Shanker Gupta, PhD
Dr. Shanker Gupta has stepped up to take on the role of Acting Editor-in-Chief while PDA conducts the search for a permanent Editor. Richard V. Levy, PhD, retired as Editor-in-Chief of the PDA Journal of Pharmaceutical Science and Technology (JPST) after almost four years as its head. Gupta has been a member of the Journal Editorial Board since 2019 and, most recently, has served as an Associate Editor, helping evaluating and managing JPST submissions. He has been a PDA member for more than 30 years.
Gupta has worked with the National Institutes of Health for almost 20 years, currently as a senior scientist in the Division of Cancer Prevention of the National Cancer Institute and consulting with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases. At NIH, he has been responsible for managing multiple translational projects designed to generate clinical product for use in Phase I and Phase 2 clinical trials. Gupta also collaborates with contract teams and actively participates in the design and development of formulations of several promising agents that have resulted in patent filings. He has supported over 40 IND submissions.
Gupta holds a BS (Hons) in pharmacy from the University of Florida and a PhD in pharmaceutical chemistry from the University of Michigan, Ann Arbor. Prior to joining NIH, he was a project leader in sterile products development at Abbott Laboratories and filed the IND for the expanded use of a lung surfactant product (Survanta®), which was the first product of its kind for neonatal respiratory distress syndrome. Gupta has published more than 20 papers in various peer-reviewed journals and contributed to books.
Associate Editors
Michael (Mike) Sadowski, Baxter Healthcare Corporation  |
Ghada Haddad, PhD, Merck & Co. |
|
Editorial Board |
||
|
James Akers, PhD, Akers Kennedy & Associates
|
 Jose Caraballo, MBA/ME, Kite Pharma, a Gilead Company
|
|
 Dayue Chen, PhD, Genentech, a Member of the Roche Group
|
H. Gregg Claycamp, PhD, Consultant (U.S. FDA, retired) |
|
 Tony Cundell, PhD, Microbiological Consulting, LLC
|
 Fenton Fong, MSc, xCellarate Technology Consulting Inc.
|
|
|
Shanker Gupta, PhD, U.S. National Institutes of Health
|
Ghada Haddad, PhD, Merck & Co. |
|
Ankur Kulshrestha, PhD, Bristol Myers Squibb
|
 Kelvin Lee, PhD, NIIMBL
|
|
Richard V. Levy, PhD, PDA (ret.)
|
 Duncan Low, PhD, Claymore Biopharm LLC
|
|
 Hanns-Christian Mahler, PhD, ten23 health AG
|
Murali Muralidhara, PhD, RVAC Medicines |
|
|
Neha Pardeshi, PhD, Amgen
|
 Jai Pathak, PhD, AztraZeneca
|
|
|
Michael (Mike) Sadowski, Baxter Healthcare Corporation
|
 Tim Sandle, PhD, Bio Products Laboratory Limited
|
|
 Alicja Sobantka, PhD, Octapharma |
 István Szikora, MBA/MS, Novartis
|
|
 Edward C. Tidswell, PhD, Merck
|
 Henrietta Vinnerås, MSc, Fresenius Kabi AB
|
|
 Kelly Waldron, PhD, ValSource Inc.
|
 Wesley Workman, PhD, Workman Biotech Consultants, LLC
|
|
 Glenn Wright, PDA, Inc. |
 Earl Zablackis, PhD, Sanofi Pasteur
|
|
 Steve Zdravkovic, Baxter International Inc.
|
 Qingyu Zeng, PhD, West Pharmaceutical Services, Inc.
|
|
 Daniele Zuccato, MS, SCHOTT Pharma |
PDA, Inc., Leadership
Chair
Susan Schniepp, Regulatory Compliance Associates Inc.
Chair-elect
Anil Sawant, PhD, Merck & Co., Inc./Merck Sharp & Dohme
Treasurer
Melissa Seymour, Biogen, Inc.
Secretary
Emma Ramnarine, PhD, Genentech/Roche
Immediate Past Chair
Jette Christensen, Novo Nordisk
Directors
Cristiana Campa, PhD, GSK
Javier Camposano, PhD, Celltrion
Mirko Gabriele, PhD, Thermo Fisher Scientific
Mark Gloglovsky, ValSource Inc.
Andrew Hopkins, Abbvie
Stephan Krause, PhD, Bristol Myers Squibb
Ivy Louis, VIENNI Training & Consulting LLP
Amy McDaniel, PhD, Bristol Myers Squibb
Cylia Chen Ooi, Amgen
Osamu Shirokizawa, Life Scienta Ltd.
PDA Staff Liaisons
Glenn E. Wright, President & CEO
Walter Morris, Sr. Director, Publishing & Press Relations